181 related articles for article (PubMed ID: 6851554)
1. Pharmacokinetics of oral contraceptive steroids after morning or evening administration.
Kiriwat O; Fotherby K
Contraception; 1983 Feb; 27(2):153-60. PubMed ID: 6851554
[TBL] [Abstract][Full Text] [Related]
2. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
[TBL] [Abstract][Full Text] [Related]
4. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
5. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
6. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of norethisterone in humans.
Shi YE; He CH; Gu J; Fotherby K
Contraception; 1987 May; 35(5):465-75. PubMed ID: 3621943
[TBL] [Abstract][Full Text] [Related]
8. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
[TBL] [Abstract][Full Text] [Related]
9. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
10. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
11. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Song S; Chen JK; He ML; Fotherby K
Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
[TBL] [Abstract][Full Text] [Related]
12. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
Toddywalla VS; Mehta S; Virkar KD; Saxena BN
Contraception; 1980 Mar; 21(3):217-23. PubMed ID: 7389350
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone.
Stanczyk FZ; Gale JA; Goebelsmann U; Nerenberg C; Matin S
Contraception; 1980 Nov; 22(5):457-70. PubMed ID: 7471737
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
16. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.
Stanczyk FZ; Mroszczak EJ; Ling T; Runkel R; Henzl M; Miyakawa I; Goebelsmann U
Contraception; 1983 Sep; 28(3):241-51. PubMed ID: 6641224
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Watts MJ
Contraception; 1979 Sep; 20(3):263-73. PubMed ID: 509953
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
20. A study of interaction of low-dose combination oral contraceptive with Ampicillin and Metronidazole.
Joshi JV; Joshi UM; Sankholi GM; Krishna U; Mandlekar A; Chowdhury V; Hazari K; Gupta K; Sheth UK; Saxena BN
Contraception; 1980 Dec; 22(6):643-52. PubMed ID: 7214911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
